Treatment of Crohn's disease with azathioprine: a controlled evaluation.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D000941:Antigens; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D007111:Immunity, Cellular; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012882:Skin Tests; D013607:Tablets; D013997:Time Factors
D000941:Antigens; D010919:Placebos; D013607:Tablets; D001379:Azathioprine